Hematopoietic niche and bone meet

Current Opinion in Supportive and Palliative Care

Volumn 2, Issue 3, 2008, Pages 211-217

  Frisch, Benjamin J ^a   Porter, Rebecca L ^a   Calvi, Laura M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Hematopoietic stem cells; Niche; Notch

Indexed keywords

ADIPOCYTE; BLOOD DISEASE; BONE MARROW; BONE TUMOR; CELL TRANSFORMATION; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; METASTASIS; NERVE CELL; OSTEOBLAST; OSTEOCLAST; PATHOLOGY; REVIEW;

ADIPOCYTES; BONE MARROW; BONE NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELLS; HUMANS; NEURONS; OSTEOBLASTS; OSTEOCLASTS;

EID: 54049115569     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32830d5c12     Document Type: Article

References (101)

1. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978; 4:7-25.
2. Taichman RS, Emerson SG. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 1994; 179:1677-1682.
3. Marusic A, Kalinowski JF, Jastrzebski S, Lorenzo JA. Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells. J Bone Miner Res 1993; 8:617-624.
4. Taichman RS, Reilly MJ, Emerson SG. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 1996; 87:518-524.
5. El-Badri NS, Wang BY, Cherry, Good RA. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp Hematol 1998; 26:110-116.
6. Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001; 97:2293-2299.
7. Adams GB, Martin RP, Alley IR, et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 2007; 25:238-243.
8. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425:841 -846.
9. Zhang J, Niu C, Ye L, etal. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425:836-841.
10. Visnjic D, Kalajzic Z, Rowe DW, etal. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 2004; 103:3258-3264.
11. Haylock DN, Williams B, Johnston HM, et al. Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells 2007; 25:1062-1069.
12. Kiel MJ, Yilmaz OH, Iwashita T, et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121:1109-1121.
13. Sipkins DA, Wei X, Wu JW, etal. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005; 435:969-973.
14. Chute JP, Muramoto GG, Dressman HK, et al. Molecular profile and partial functional analysis of novel endothelial cell-derived growth factors that regulate hematopoiesis. Stem Cells 2006; 24:1315-1327.
15. Kollet O, Dar A, Shivtiel S, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006; 12:657-664.
16. Lymperi S, Horwood N, Marley S, et al. Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood 2008; 111:1173-1181.
17. KatayamaY, BattistaM, Kao WM, etal. Signals from the sympatheticnervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006; 124:407-421.
18. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008; 452:442-447.
19. DiMascio L, Voermans C, Uqoezwa M, etal. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 2007; 178:3511 -3520.
20. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270:26746-26749.
21. Berner HS, Lyngstadaas SP, Spahr A, et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004; 35:842-849.
22. Milner LA, Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood 1999; 93:2431 -2448.
23. Lai EC. Notch signaling: control of cell communication and cell fate. Development 2004; 131:965-973.
24. Karanu FN, Murdoch B, Gallacher L, et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells.J Exp Med 2000; 192:1365-1372.
25. Karanu FN, Murdoch B, Miyabayashi T, et al. Human homologues ofDelta-1 and Delta-4 function as mitogenic regulators of primitive human hemato-poietic cells. Blood 2001; 97:1960-1967.
26. Karanu FN, Yuefei L, Gallacher L, et al. Differential response of primitive human CD34- and CD34+ hematopoietic cells to the Notch ligand Jagged-1. Leukemia 2003; 17:1366-1374.
27. Ohishi K, Varnum-Finney B, Bernstein ID. The notch pathway: modulation of cell fate decisions in hematopoiesis. Int J Hematol 2002; 75:449-459.
28. Shojaei F, Trowbridge J, Gallacher L, et al. Hierarchical and ontogenic positions serve to define the molecular basis of human hematopoietic stem cell behavior. Dev Cell 2005; 8:651 -663.
29. Varnum-Finney B, Xu L, Brashem-Stein C, et al. Pluripotent, cytokine- dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 2000; 6:1278-1281.
30. Li L, Milner LA, Deng Y, etal. The human homolog of rat Jagged1 expressed bymarrowstromainhibits differentiation of32D cells through interaction with Notch1. Immunity 1998; 8:43-55.
31. Bolos V, Grego-BessaJ, de la Pompa JL. Notch signaling in development and cancer. Endocr Rev 2007; 28:339-363.
32. Deregowski V, Gazzerro E, Priest L, etal. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morpho- genetic protein signaling. J Biol Chem 2006; 281:6203-6210.
33. Fiuza UM, Arias AM. Cell and molecular biology of Notch. J Endocrinol 2007; 194:459-474.
34. Nobta M, Tsukazaki T, Shibata Y, et al. Critical regulation of bone morpho- genetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. J Biol Chem 2005; 280:15842-15848.
35. Pereira RM, Delany AM, Durant D, Canalis E. Cortisol regulates the expression of Notch in osteoblasts. J Cell Biochem 2002; 85:252-258.
36. Sciaudone M, Gazzerro E, Priest L, et al. Notch 1 impairs osteoblastic cell differentiation. Endocrinology 2003; 144:5631-5639.
37. Shindo K, Kawashima N, Sakamoto K, et al. Osteogenic differentiation ofthe mesenchymal progenitor cells, Kusa is suppressed by Notch signaling. Exp Cell Res 2003; 290:370-380.
38. Watanabe N, Tezuka Y, Matsuno K, et al. Suppression ofdifferentiation and proliferation ofearlychondrogenic cells byNotch. J Bone Miner Metab 2003; 21:344-352.
39. Weber JM, Forsythe SR, Christianson CA, et al. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells.Bone 2006; 39:485-493.
40. Maillard I, Koch U, Dumortier A, et al. Canonical notch signaling is dispen- sable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2008; 2:356-366.
41. Potocnik AJ, Brakebusch C, Fassler R. Fetal and adult hematopoietic stem cells require beta1 integrin function forcolonizing fetal liver, spleen, and bone marrow. Immunity 2000; 12:653-663.
42. Vermeulen M, Le Pesteur F, Gagnerault MC, et al. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 1998; 92:894-900.
43. Wagers AJ, Allsopp RC, Weissman IL. Changes in integrin expression are associated with altered homing properties of Lin(-/lo)Thy1.1 (lo)Sca-1(+)c- kit(+) hematopoietic stem cells following mobilization by cyclophosphamide/ granulocyte colony-stimulating factor. Exp Hematol 2002; 30:176-185.
44. McKee MD, Farach-Carson MC, Butler WT, et al. Ultrastructural immuno- localization of noncollagenous (osteopontin and osteocalcin) and plasma (albumin and alpha 2HS-glycoprotein) proteinsin ratbone. J Bone Miner Res 1993; 8:485-496.
45. Nilsson SK, Johnston HM, WhittyGA, etal. Osteopontin, a keycomponentof the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005; 106:1232-1239.
46. Schmits R, Filmus J, Gerwin N, et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997; 90:2217 -2233.
47. Scott LM, Priestley GV, Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol 2003; 23:9349-9360.
48. Stier S, Ko Y, Forkert R, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005;201:1781-1791.
49. Wang MW, Consoli U, Lane CM, et al. Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells. Cell Growth Differ1998; 9:105-112.
50. Yamaguchi M, Ikebuchi K, Hirayama F, et al. Different adhesive characteristics and VLA-4 expression of CD34(+) progenitors in G0/G1 versus S+G2/M phases of the cell cycle. Blood 1998; 92:842-848.
51. Dao MA, Nolta JA. Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow. Blood 2007; 109:2373-2379.
52. Gottschling S, Saffrich R, Seckinger A, et al. Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism. Stem Cells 2007; 25:798-806.
53. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118:149-161.
54. Wilson A, Murphy MJ, Oskarsson T, et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004; 18:2747 -2763.
55. Haug JS, He XC, GrindleyJC, etal. N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2008; 2:367-379.
56. Kiel MJ, Radice GL, Morrison SJ. Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 2007; 1:204-217.
57. Jung Y, Wang J, Song J, et al. Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood 2007; 110:82-90.
58. Hsu HC, Ema H, Osawa M, et al. Hematopoietic stem cells express Tie-2 receptor in the murine fetal liver. Blood 2000; 96:3757 -3762.
59. Puri MC, Bernstein A. Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis. Proc Natl Acad Sci U S A 2003; 100:12753-12758.
60. Arai F, Ohneda O, Miyamoto T, et al. Mesenchymal stem cells in perichon- drium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 2002; 195:1549-1563.
61. Arai F, Hirao A, Suda T. Regulation ofhematopoietic stem cells by the niche. Trends Cardiovasc Med 2005; 15:75-79.
62. Ponomaryov T, Peled A, Petit I, et al. Induction of the chemokine stromal- derived factor-1 following DNA damage improves human stem cell function.J Clin Invest 2000; 106:1331-1339.
63. Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005; 201:1307-1318.
64. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109:625-637.
65. Larochelle A, Krouse A, Metzger M, etal. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacityin nonhuman primates. Blood2006; 107:3772-3778.
66. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hemato- poietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006; 25:977 -988.
67. Peled A, Petit I, Kollet O, et al. Dependence ofhuman stem cell engraftment and repopulation ofNOD/SCID mice on CXCR4. Science 1999; 283:845-48.
68. Jung Y, Wang J, Schneider A, et al. Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 2006; 38:497 -508.
69. Ma Q, Jones D, Borghesani PR, etal. Impaired B-lymphopoiesis, myelopoi- esis, and derailed cerebellar neuron migration in CXCR4- and SDF-1- deficient mice. Proc Natl Acad Sci U S A 1998; 95:9448-9453.
70. Zou YR, Kottmann AH, Kuroda M, et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-599.
71. Rossi L, Manfredini R, Bertolini F, et al. The extracellular nucleotide UTP is a potentinducerofhematopoieticstemcellmigration.Blood2007;109: 533-542.
72. Sierro F, Biben C, Martinez-Munoz L, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A2007; 104:14759-14764.
73. Rodan SB, Rodan GA, Simmons HA, et al. Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2. Biochem Biophys Res Commun 1981; 102:1358-1365.
74. North TE, Goessling W, Walkley CR, et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007; 447:1007 -1011.
75. Tetradis S, Pilbeam CC, Liu Y, et al. Parathyroid hormone increases pros- taglandin G/H synthase-2 transcription by a cyclic adenosine 3',5'-mono- phosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells. Endocrinology 1997; 138:3594-3600.
76. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423:409-414.
77. Willert K, Brown JD, Danenberg E, et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003; 423:448-452.
78. Murdoch B, Chadwick K, Martin M, et al. Wnt-5A augments repopulating capacityandprimitivehematopoieticdevelopmentofhumanbloodstemcells in vivo. Proc Natl Acad Sci U S A 2003; 100:3422-3427.
79. Zhou H, Mak W, Zheng Y, et al. Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem 2008; 283:1936-1945.
80. Fleming HE, Janzen V, Lo Celso C, et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self- renewal in vivo. Cell Stem Cell 2008; 2:274-283.
81. Nemeth MJ, Topol L, Anderson SM, et al. Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. Proc Natl Acad Sci U S A 2007; 104:15436-15441.
82. Adams GB, Chabner KT, Alley IR, et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006; 439:599-603.
83. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironmentbeneathadherentmacrophagesandosteoclasts.ExpCell Res 1988; 175:266-276.
84. Walkley CR, Shea JM, Sims NA, et al. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 2007; 129:1081 -1095.
85. Walkley CR, Olsen GH, Dworkin S, et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 2007; 129:1097-1110.
86. Zhang Z, Vuori K, Reed JC, Ruoslahti E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A 1995; 92:6161 -6165.
87. Damiano JS, Cress AE, Hazlehurst LA, et al. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 1999; 93:1658-1667.
88. Hazlehurst LA, Argilagos RF, Emmons M, et al. Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells.Cancer Res 2006; 66:2338-2345.
89. Hazlehurst LA, Damiano JS, Buyuksal I, et al. Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene 2000; 19:4319-4327.
90. Hazlehurst LA, Enkemann SA, Beam CA, et al. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res 2003; 63:7900-7906.
91. Tabe Y, Jin L, Tsutsumi-Ishii Y, et al. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow- derived stromal cells. Cancer Res 2007; 67:684-694.
92. Mohle R, Bautz F, Rafii S, et al. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced bystromal cell-derived factor-1.Blood 1998; 91:4523-4530.
93. Mohle R, Schittenhelm M, Failenschmid C, et al. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Br J Haematol 2000; 110:563-572.
94. Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.Nat Biotechnol 2007; 25:1315-1321.
95. Zhao C, Blum J, Chen A, et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007; 12:528-541.
96. Guo W, Lasky JL, Chang CJ, et al. Multigenetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 2008;453:529-533.
97. Yilmaz OH, Valdez R, Theisen BK, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441:475-482.
98. ZhangJ,GrindleyJC,YinT,etal.PTENmaintainshaematopoieticstemcells and acts in lineage choice and leukaemia prevention. Nature 2006;441:518-522.
99. Jin L, Hope KJ, Zhai Q, et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. NatMed 2006; 12:1167-1174.
100. Matsunaga T, Fukai F, Miura S, et al. Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia. Leukemia 2008; 22:353-360.
101. Zhao Y, Bachelier R, Treilleux I, et al. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res 2007; 67:5821-5830.